fda and compounded glp 1 is moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs signaling stronger enforcement to protect patients from unverified Congress Introduces SAFE Drugs Act

We're now seeing research into 'tri-agonists' and other combination molecules that could offer even greater efficacy, potentially with different dosing profiles

We focus on improving your overall well-being through customized treatments that address the root causes of weight gain

Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma

Significant weight loss accumulates over months

Tonic-clonic seizures (grand mal): is one of the most severe types of clinical seizures where the entire brain can demonstrate abnormal electrical activity

Potential adverse effects of these drugs include hypoglycemia (when taken with insulin), GI distress, and injection site reactions